GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries

Divino, V; DeKoven, M; Khan, FA; Boye, KS; Sapin, H; Norrbacka, K

Divino, V (reprint author), QuintilesIMS, Fairfax, VA 09762 USA.

DIABETES THERAPY, 2017; 8 (1): 115

Abstract

Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a relatively new class of injectable drugs used in the treatment of type 2 dia......

Full Text Link